[go: up one dir, main page]

IT1276783B1 - Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali - Google Patents

Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali

Info

Publication number
IT1276783B1
IT1276783B1 IT95MI001359A ITMI951359A IT1276783B1 IT 1276783 B1 IT1276783 B1 IT 1276783B1 IT 95MI001359 A IT95MI001359 A IT 95MI001359A IT MI951359 A ITMI951359 A IT MI951359A IT 1276783 B1 IT1276783 B1 IT 1276783B1
Authority
IT
Italy
Prior art keywords
prophylaxis
pharmaceutical
treatment
pct
gastrointestinal diseases
Prior art date
Application number
IT95MI001359A
Other languages
English (en)
Inventor
Haen Christoph De
Luigia Gozzini
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of ITMI951359A0 publication Critical patent/ITMI951359A0/it
Priority to IT95MI001359A priority Critical patent/IT1276783B1/it
Priority to JP9503576A priority patent/JPH11507934A/ja
Priority to CN96194976A priority patent/CN1082373C/zh
Priority to PCT/EP1996/002650 priority patent/WO1997000688A1/en
Priority to AU63575/96A priority patent/AU707399B2/en
Priority to CA002219739A priority patent/CA2219739A1/en
Priority to US08/973,676 priority patent/US6007808A/en
Priority to DE69626818T priority patent/DE69626818T2/de
Priority to DE0833644T priority patent/DE833644T1/de
Priority to ES96922842T priority patent/ES2194107T3/es
Priority to MX9709238A priority patent/MX9709238A/es
Priority to EP96922842A priority patent/EP0833644B1/en
Priority to NZ312121A priority patent/NZ312121A/xx
Priority to HU9901707A priority patent/HUP9901707A3/hu
Priority to DK96922842T priority patent/DK0833644T3/da
Priority to AT96922842T priority patent/ATE234623T1/de
Priority to BR9609413A priority patent/BR9609413A/pt
Priority to ZA965235A priority patent/ZA965235B/xx
Publication of ITMI951359A1 publication Critical patent/ITMI951359A1/it
Application granted granted Critical
Publication of IT1276783B1 publication Critical patent/IT1276783B1/it
Priority to NO976048A priority patent/NO976048L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • Confectionery (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT95MI001359A 1995-06-23 1995-06-23 Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali IT1276783B1 (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT95MI001359A IT1276783B1 (it) 1995-06-23 1995-06-23 Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
MX9709238A MX9709238A (es) 1995-06-23 1996-06-19 Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
NZ312121A NZ312121A (en) 1995-06-23 1996-06-19 Pharmaceutical compositions comprising an intestinal eubiotic bacterial strain and glutamine
PCT/EP1996/002650 WO1997000688A1 (en) 1995-06-23 1996-06-19 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
AU63575/96A AU707399B2 (en) 1995-06-23 1996-06-19 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
CA002219739A CA2219739A1 (en) 1995-06-23 1996-06-19 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
US08/973,676 US6007808A (en) 1995-06-23 1996-06-19 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
DE69626818T DE69626818T2 (de) 1995-06-23 1996-06-19 Zusammensetzung welche einen darmbakterienstamm und glutamin enthält
DE0833644T DE833644T1 (de) 1995-06-23 1996-06-19 Zusammensetzung welche einen darmbakterienstamm und glutamin enthält
ES96922842T ES2194107T3 (es) 1995-06-23 1996-06-19 Formulaciones farmaceuticas y dieteticas para la profilaxis y tratamiento de trastornos gastrointestinales.
JP9503576A JPH11507934A (ja) 1995-06-23 1996-06-19 胃腸障害の予防及び治療のための医薬用及び食餌用処方
EP96922842A EP0833644B1 (en) 1995-06-23 1996-06-19 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
CN96194976A CN1082373C (zh) 1995-06-23 1996-06-19 预防和治疗胃肠疾病的药物和饮食制品
HU9901707A HUP9901707A3 (en) 1995-06-23 1996-06-19 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
DK96922842T DK0833644T3 (da) 1995-06-23 1996-06-19 Farmaceutisk og diætetiske sammensætninger til forebyggelse og behandling af gastrointestinale sygdomme
AT96922842T ATE234623T1 (de) 1995-06-23 1996-06-19 Zusammensetzung welche einen darmbakterienstamm und glutamin enthält
BR9609413A BR9609413A (pt) 1995-06-23 1996-06-19 Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
ZA965235A ZA965235B (en) 1995-06-23 1996-06-20 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
NO976048A NO976048L (no) 1995-06-23 1997-12-22 Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001359A IT1276783B1 (it) 1995-06-23 1995-06-23 Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali

Publications (3)

Publication Number Publication Date
ITMI951359A0 ITMI951359A0 (it) 1995-06-23
ITMI951359A1 ITMI951359A1 (it) 1996-12-23
IT1276783B1 true IT1276783B1 (it) 1997-11-03

Family

ID=11371866

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95MI001359A IT1276783B1 (it) 1995-06-23 1995-06-23 Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali

Country Status (18)

Country Link
US (1) US6007808A (it)
EP (1) EP0833644B1 (it)
JP (1) JPH11507934A (it)
CN (1) CN1082373C (it)
AT (1) ATE234623T1 (it)
AU (1) AU707399B2 (it)
BR (1) BR9609413A (it)
CA (1) CA2219739A1 (it)
DE (2) DE69626818T2 (it)
DK (1) DK0833644T3 (it)
ES (1) ES2194107T3 (it)
HU (1) HUP9901707A3 (it)
IT (1) IT1276783B1 (it)
MX (1) MX9709238A (it)
NO (1) NO976048L (it)
NZ (1) NZ312121A (it)
WO (1) WO1997000688A1 (it)
ZA (1) ZA965235B (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US6641808B1 (en) * 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
CA2407724A1 (en) * 2000-05-03 2001-11-08 University Of Maryland, Baltimore Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal
US7112570B2 (en) * 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
CA2439293A1 (en) 2001-03-05 2002-09-12 Stephen P. Ernest Enteral formulation
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
JP4559380B2 (ja) * 2002-03-01 2010-10-06 日清ファルマ株式会社 肝疾患治療剤
EP1541672B1 (en) * 2002-07-22 2009-01-28 Meito Sangyo Co., Ltd. Composition for promoting the proliferation of lactobacillus casei subsp. casei
DK175877B1 (da) * 2002-11-11 2005-05-09 Pharmalett As Præparater til anvendelse som terapeutisk middel
WO2005000034A2 (en) * 2003-06-23 2005-01-06 Agtech Products, Inc. Lactic bacteria and its use in direct-fed microbials
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8877178B2 (en) * 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
AR053805A1 (es) * 2005-05-31 2007-05-23 Iams Company Bifidobacterias probioticas para felinos
JP4938005B2 (ja) * 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティックであるラクトバシラス
JPWO2007119502A1 (ja) * 2006-03-23 2009-08-27 協和発酵バイオ株式会社 便通改善剤
US20100316769A1 (en) * 2006-03-29 2010-12-16 Gail Czarnecki-Maulden Dietary supplements containing probiotics
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
CN101259140B (zh) * 2007-03-08 2012-08-22 重庆北碚现代应用药物研究所 一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2206506A1 (en) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
US20120087902A1 (en) 2009-07-20 2012-04-12 Bracco S.P.A. Therapeutic Use Of Probiotics
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US9856451B2 (en) 2011-12-28 2018-01-02 Yamada Bee Company Inc. Lactic acid bacterium having IgA production promoting activity, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US5397803A (en) * 1985-09-12 1995-03-14 Brigham And Women's Hospital Use of glutamine to reduce rate of pathogenic microorganism infection
JPH0367046A (ja) * 1989-08-05 1991-03-22 Mitsubishi Motors Corp エンジンの吸入空気量制御装置
CN1105544A (zh) * 1994-09-09 1995-07-26 扬州大学农学院 一种制取活性乳酸菌口服液的方法
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding

Also Published As

Publication number Publication date
ZA965235B (en) 1997-01-09
DK0833644T3 (da) 2003-07-21
DE69626818T2 (de) 2003-11-20
CN1188413A (zh) 1998-07-22
WO1997000688A1 (en) 1997-01-09
ATE234623T1 (de) 2003-04-15
NO976048L (no) 1998-02-23
BR9609413A (pt) 1999-05-18
JPH11507934A (ja) 1999-07-13
NO976048D0 (no) 1997-12-22
DE833644T1 (de) 1998-09-03
AU707399B2 (en) 1999-07-08
EP0833644B1 (en) 2003-03-19
CA2219739A1 (en) 1997-01-09
ITMI951359A1 (it) 1996-12-23
HUP9901707A2 (hu) 1999-09-28
HUP9901707A3 (en) 2001-04-28
CN1082373C (zh) 2002-04-10
ITMI951359A0 (it) 1995-06-23
US6007808A (en) 1999-12-28
NZ312121A (en) 1999-03-29
MX9709238A (es) 1998-03-31
DE69626818D1 (de) 2003-04-24
EP0833644A1 (en) 1998-04-08
ES2194107T3 (es) 2003-11-16
AU6357596A (en) 1997-01-22

Similar Documents

Publication Publication Date Title
IT1276783B1 (it) Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali
BG101118A (en) Therapeutical compounds
KR960700059A (ko) 파킨슨씨 병 및 파킨슨 중후군의 치료에 카르바마제핀 및 옥스카르바제핀의 이용(application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes)
DE69502939D1 (de) Sublinguales oder bukkales arzneimittel
BR9914044A (pt) ésteres tetrahidropirido
IL113941A (en) Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
DE69919533D1 (de) Proteinhaltige arzneimittel
DE69525649D1 (de) Lamotrigin haltiges arzneimittel
ES2191099T3 (es) Derivados de hidantoina como productos intermedios para principios activos farmaceuticos.
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
NZ320522A (en) Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the compounds
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
ATE170527T1 (de) Phosphonobernsteinsäurederivate und ihre verwendung als arzneimittel
YU36499A (sh) Primena 1-/4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropirid -1-il/2-(6,7-dimetoksinaft-2-il)etana za dobijanje medikamenata za neurotrofno dejstvo

Legal Events

Date Code Title Description
0001 Granted